Shareholders offload $100m stake in Luye Pharma
Three shareholders in Luye Pharma Group have raised a collective HK$775.6m ($100m) by selling some of their shares in the company, which made its debut on the Hong Kong Stock Exchange in July last year. Books for the block only remained open for an hour, but that was long enough for the deal to be multiple times covered despite the stock being offered at a very tight discount.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: